Study Title: A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects with Advanced/Metastatic Solid Tumors
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Theodore Gourdin, at gourdith@musc.edu.Study Coordinator, Holly Boggan, at bogganhl@musc.edu, or please call +1 843-792-8068.Trial opened at the following institutions: Medical University of South Carolina